Table 4. Local people living with HIV/AIDS (PLHA) covered with follow-up care, tested for CD4, initiated and retained antiretroviral therapy (ART), before and after the task shifting from government health facilities to community-based organizations (CBOs), 2008 to 2012, Nanjing, China.
| Year | Enrollment oflocal PLHA alive | CD4 test† | Number of ARTeligibility‡ | ART initiation | 12 month ARTretention rate§ % (n) | ||
| n | % | n | % | ||||
| 2008 | 232 | 165 | 71.1(165/232) | 84 | 66 | 78.6(66/84) | 95.5(63/66) |
| 2009 | 400 | 287 | 71.0(287/400) | 143 | 108 | 75.5(108/143) | 96.3(104/108) |
| 2010 | 572 | 442 | 77.3(442/572) | 261 | 188 | 72.0(188/261) | 96.3(181/188) |
| 2011 | 792 | 596 | 75.3(596/792) | 408 | 346 | 84.8(346/408) | 97.1(336/346) |
| 2012 | 1,090 | 937 | 86.0(937/1,090) | 574 | 517 | 90.1(517/574) | 97.7(505/517) |
†
CD4 test defined as PLHA received CD4 tests at least one time within a year.
‡
The criterion of ART eligibility is CD4 <200 cells/uL prior to and in 2011, and ≤350 cells/uL in 2012 and afterwards.
§
The number of ART initiation was 42 in 2007.
P values for trend analyses: P<0.01 for follow-up care, P<0.05 for CD4 tests, P<0.05 for ART coverage, and P>0.05 for 12-month ART retention rate.